Skip to content
Dx

HCPCS Level II · Medical services and quality measures

M1415Patients who did not have a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapy

✓ Active

Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.

About M1415

M1415 is an HCPCS Level II code in the M series (medical services and quality measures), describing patients who did not have a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapy.

It was added to HCPCS effective 01/01/2025.

Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.

Details

Short description
No pos pdl1 bef ici ther
Date added
01/01/2025
Action effective
01/01/2025
BETOS
Z2

Related M14xx codes

Common questions about M1415

Is HCPCS M1415 still valid?

Yes. M1415 is active in the CMS October 2026 HCPCS file.

Does Medicare cover M1415?

Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.